Polymorphisms of the IgH enhancer HS1.2 and risk of systemic lupus erythematosus

Annals of the Rheumatic Diseases

Volumn 71, Issue 8, 2012, Pages 1309-1315

  Frezza, Domenico ^a   Tolusso, Barbara ^b   Giambra, Vincenzo ^c   Gremese, Elisa ^b   Marchini, Maurizio ^d   Nowik, Marcin ^b   Serone, Eliseo ^a   D'Addabbo, Pietro ^e   Mattioli, Claudia ^a   Canestri, Silvia ^b   Petricca, Luca ^b   D'Antona, Graziella ^b   Birshtein, Barbara K ^f   Scorza, Raffaella ^d   Ferraccioli, Gianfranco ^b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c BRITISH COLUMBIA CANCER AGENCY   (Canada)

^d UNIVERSITY OF MILAN   (Italy)

^e UNIVERSITY OF BARI   (Italy)

^f ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B CELL ACTIVATING FACTOR RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN M; TRANSCRIPTION FACTOR SP1;

ADULT; ALLELE; ANTIBODY BLOOD LEVEL; ARTICLE; B LYMPHOCYTE; BINDING SITE; COHORT ANALYSIS; CONSENSUS SEQUENCE; CONTROLLED STUDY; DNA POLYMORPHISM; ENHANCER REGION; FEMALE; GENE; GENE FREQUENCY; GENETIC RISK; GENETIC VARIABILITY; HS1.2 GENE; HUMAN; HUMAN CELL; IMMUNOGLOBULIN HEAVY CHAIN GENE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; BASE SEQUENCE; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULINS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MOLECULAR SEQUENCE DATA; NF-KAPPA B; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 84863840834     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2010.147025     Document Type: Article

References (41)

1. Shlomchik MJ. Activating systemic autoimmunity: Bs, Ts, and Tolls. Curr Opin Immunol 2009;21:626-33.
2. Manolio TA, Collins FS, Cox NJ, et al. Finding the missing heritability of complex diseases. Nature 2009;461:747-53.
3. Doreau A, Belot A, Bastid J, et al. Interleukin 17 acts in synergy with B cellactivating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus. Nat Immunol 2009;10:778-85.
4. Nashi E, Wang Y, Diamond B. The role of B cells in lupus pathogenesis. Int J Biochem Cell Biol 2010;42:543-50.
5. Pinaud E, Marquet M, Fiancette R, et al. The IgH locus 3′ regulatory region: pulling the strings from behind. Adv Immunol 2011;110:27-70.
6. Laurencikiene J, Tamosiunas V, Severinson E. Regulation of epsilon germline transcription and switch region mutations by IgH locus 3′ enhancers in transgenic mice. Blood 2007;109:159-67. (Pubitemid 46053057)
7. Dunnick WA, Collins JT, Shi J, et al. Switch recombination and somatic hypermutation are controlled by the heavy chain 3′ enhancer region. J Exp Med 2009;206:2613-23.
8. Vincent-Fabert C, Fiancette R, Pinaud E, et al. Genomic deletion of the whole IgH 3′ regulatory region (hs3a, hs1,2, hs3b, and hs4) dramatically affects class switch recombination and Ig secretion to all isotypes. Blood 2010;116:1895-8.
9. Chatterjee S, Ju Z, Hassan R, et al. Dynamic changes in binding of immunoglobulin heavy chain 3′ regulatory region to protein factors during class switching. J Biol Chem 2011;286:29303-12.
10. Chauveau C, Cogné M. Palindromic structure of the IgH 3′ locus control region. Nat Genet 1996;14:15-6.
11. D'Addabbo P, Scascitelli M, Giambra V, et al. Position and sequence conservation in amniota of polymorphic enhancer HS1.2 within the palindrome of IgH 3′ regulatory region. BMC Evol Biol 2011;11:71.
12. Mills FC, Harindranath N, Mitchell M, et al. Enhancer complexes located downstream of both human immunoglobulin Calpha genes. J Exp Med 1997;186:845-58. (Pubitemid 27407346)
13. Giambra V, Fruscalzo A, Giufré M, et al. Evolution of human IgH3′EC duplicated structures: both enhancers HS1,2 are polymorphic with variation of transcription factor's consensus sites. Gene 2005;346:105-14. (Pubitemid 40332628)
14. Denizot Y, Pinaud E, Aupetit C, et al. Polymorphism of the human alpha1 immunoglobulin gene 3′ enhancer hs1,2 and its relation to gene expression. Immunology 2001;103:35-40. (Pubitemid 32454522)
15. Laurencikiene J, Deveikaite V, Severinson E. HS1,2 enhancer regulation of germline epsilon and gamma2b promoters in murine B lymphocytes: evidence for specific promoter-enhancer interactions. J Immunol 2001;167:3257-65. (Pubitemid 32852566)
16. Kim EC, Edmonston CR, Wu X, et al. The HoxC4 homeodomain protein mediates activation of the immunoglobulin heavy chain 3′ hs1,2 enhancer in human B cells. Relevance to class switch DNA recombination. J Biol Chem 2004;279:42258-69. (Pubitemid 39313675)
17. Ong J, Stevens S, Roeder RG, et al. 3′ IgH enhancer elements shift synergistic interactions during B cell development. J Immunol 1998;160:4896-903. (Pubitemid 28215324)
18. Aupetit C, Drouet M, Pinaud E, et al. Alleles of the alpha1 immunoglobulin gene 3′ enhancer control evolution of IgA nephropathy toward renal failure. Kidney Int 2000;58:966-71.
19. Frezza D, Giambra V, Cianci R, et al. Increased frequency of the immunoglobulin enhancer HS1,2 allele 2 in coeliac disease. Scand J Gastroenterol 2004;39:1083-7. (Pubitemid 39536397)
20. Cianci R, Giambra V, Mattioli C, et al. Increased frequency of Ig heavy-chain HS1,2-A enhancer*2 allele in dermatitis herpetiformis, plaque psoriasis, and psoriatic arthritis. J Invest Dermatol 2008;128:1920-4. (Pubitemid 352001222)
21. Frezza D, Giambra V, Tolusso B, et al. Polymorphism of immunoglobulin enhancer element HS1,2A: allele*2 associates with systemic sclerosis. Comparison with HLA-DR and DQ allele frequency. Ann Rheum Dis 2007;66:1210-5. (Pubitemid 47309739)
22. Tolusso B, Frezza D, Mattioli C, et al. Allele*2 of the HS1,2A enhancer of the Ig regulatory region associates with rheumatoid arthritis. Ann Rheum Dis 2009;68:416-9.
23. Frezza D, Giambra V, Mattioli C, et al. Allelic frequencies of 3′ Ig heavy chain locus enhancer HS1,2-A associated with Ig levels in patients with schizophrenia. Int J Immunopathol Pharmacol 2009;22:115-23.
24. Giambra V, Cianci R, Lolli S, et al. Allele*1 of HS1.2 enhancer associates with selective IgA deficiency and IgM concentration. J Immunol 2009;183:8280-5.
25. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7. (Pubitemid 13221242)
26. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
27. Schreiber E, Matthias P, Müller MM, et al. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res 1989;17:6419. (Pubitemid 19198635)
28. Fujita T, Nolan GP, Ghosh S, et al. Independent modes of transcriptional activation by the p50 and p65 subunits of NF-kappa B. Genes Dev 1992;6:775-87.
29. Michaelson JS, Singh M, Snapper CM, et al. Regulation of 3′ IgH enhancers by a common set of factors, including kappa B-binding proteins. J Immunol 1996;156:2828-39. (Pubitemid 126660629)
30. Zelazowski P, Shen Y, Snapper CM. NF-kappaB/p50 and NF-kappaB/c-Rel differentially regulate the activity of the 3′alphaE-hsl,2 enhancer in normal murine B cells in an activation-dependent manner. Int Immunol 2000;12:1167-72. (Pubitemid 30618022)
31. Sepulveda MA, Emelyanov AV, Birshtein BK. NF-kappa B and Oct-2 synergize to activate the human 3′ IgH hs4 enhancer in B cells. J Immunol 2004;172:1054-64. (Pubitemid 38113765)
32. Fu L, Lin-Lee YC, Pham LV, et al. BAFF-R promotes cell proliferation and survival through interaction with IKKbeta and NF-kappaB/c-Rel in the nucleus of normal and neoplastic B-lymphoid cells. Blood 2009;113:4627-36.
33. Pasparakis M, Schmidt-Supprian M, Rajewsky K. IkB kinase signalling is essential for maintenance of mature B cells. J Exp Med 2002;193:417-26.
34. Kaisho T, Takeda K, Tsujimura T, et al. IkappaB kinase alpha is essential for mature B cell development and function. J Exp Med 2001;193:417-26. (Pubitemid 32524473)
35. Demchenko YN, Kuehl WM. A critical role for the NFkB pathway in multiple myeloma. Oncotarget 2010;1:59-68.
36. Rauch M, Tussiwand R, Bosco N, et al. Crucial role for BAFF-BAFF-R signaling in the survival and maintenance of mature B cells. PLoS ONE 2009;4:e5456.
37. Kern C, Cornuel JF, Billard C, et al. Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway. Blood 2004;103:679-88. (Pubitemid 38145555)
38. Garrett FE, Emelyanov AV, Sepulveda MA, et al. Chromatin architecture near a potential 3′ end of the igh locus involves modular regulation of histone modifications during B cell development and in vivo occupancy at CTCF sites. Mol Cell Biol 2005;25:1511-25. (Pubitemid 40204926)
39. Giambra V, Volpi S, Emelyanov AV, et al. Pax5 and linker histone H1 coordinate DNA methylation and histone modifications in the 3′ regulatory region of the immunoglobulin heavy chain locus. Mol Cell Biol 2008;28:6123-33.
40. Wuerffel R, Wang L, Grigera F, et al. S-S synapsis during class switch recombination is promoted by distantly located transcriptional elements and activation-induced deaminase. Immunity 2007;27:711-22. (Pubitemid 350110545)
41. Hewitt SL, Farmer D, Marszalek K, et al. Association between the Igk and Igh immunoglobulin loci mediated by the 3′ Igk enhancer induces 'decontraction' of the Igh locus in pre-B cells. Nat Immunol 2008;9:396-404. (Pubitemid 351405109)